SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-13-002048
Filing Date
2013-05-24
Accepted
2013-05-24 12:32:10
Documents
4
Period of Report
2013-05-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_052213.htm 8-K 36013
2 FORM OF AMENDMENT TO ARTICLES OF INCORPORATION ex3-1a.htm EX-3.1A 25871
3 AMENDMENT TO BYLAWS ex3-2a.htm EX-3.2A 9924
4 AUDIT COMMITTEE CHARTER ex10-33.htm EX-10.33 35111
  Complete submission text file 0001387131-13-002048.txt   108381
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-88480 | Film No.: 13871015
SIC: 2834 Pharmaceutical Preparations